InvestorsHub Logo
Followers 3
Posts 619
Boards Moderated 0
Alias Born 03/17/2017

Re: A deleted message

Monday, 04/08/2019 11:52:06 AM

Monday, April 08, 2019 11:52:06 AM

Post# of 8299
Well it’s one of the risks noted in the 10K. Have you read it?

With limited funding and no other trials in the works, Tenax is relying on the success of levosimendan. Additionally, they’ll need to be successful at commercializing it in the case that it is approved. They won’t be able to fund another trial.

It’s not blatant negativity as I’m stating what’s in the 10K
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TENX News